Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibogaine for Methadone Detoxification
NCT04003948Phase 2Completed
- Sponsor
- ICEERS
- Start
- Oct 2020
- Primary completion
- Apr 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ibogaine in opioid use disorder (OUD), sponsored by ICEERS. Started Oct 2020; status: completed.
02
Drugs
ibogaine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04003948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04003948.